Ledger.Open graph →
SEC Form D · filed April 7, 2014

scPharmaceuticals Inc

Offering
$17.1M
Sold
$9.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Kush Parmar · Boston, MADirectorPieter Muntendam · Waltham, MAExec · DirectorMette K. Agger · Boston, MADirectorKush Parmar · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗